Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01627080
What this trial is testing

Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center
Very early researchStudy completedNCT03196180
What this trial is testing

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2/3Cervical Squamous Cell Carcinoma In SituCervical Squamous Intraepithelial Neoplasia 2+1 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Active Not RecruitingNCT04874480
What this trial is testing

Tegavivint for the Treatment of Relapsed or Refractory Leukemia

Who this might be right for
Recurrent LeukemiaRefractory Leukemia
M.D. Anderson Cancer Center 9
Early research (Phase 1)Study completedNCT00004079
What this trial is testing

Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 46
Not applicableUnknownNCT02646462
What this trial is testing

Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Michael Bau Mortensen 200
Testing effectiveness (Phase 2)WithdrawnNCT02252978
What this trial is testing

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences
Not applicableStudy completedNCT05886478
What this trial is testing

A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

Who this might be right for
T-Cell Lymphoma
Takeda 26
Early research (Phase 1)Study completedNCT02303678
What this trial is testing

D2C7 for Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaBrain Tumor, Recurrent
Darell Bigner 81
Large-scale testing (Phase 3)Study completedNCT02366143
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 1,202
Early research (Phase 1)Study completedNCT01388335
What this trial is testing

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

Who this might be right for
Solid TumorLymphoma, Malignant
Eli Lilly and Company 13
Early research (Phase 1)UnknownNCT04678908
What this trial is testing

Injection HB0025 in Patients With Advanced Solid Tumors

Who this might be right for
Tumor, Subjects
Huabo Biopharm Co., Ltd. 154
Testing effectiveness (Phase 2)Study completedNCT02805725
What this trial is testing

Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide

Who this might be right for
Soft-tissue Sarcomas
Institut Bergonié 50
Not applicableStudy completedNCT04394325
What this trial is testing

Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer

Who this might be right for
Breast Cancer
Jonkoping University 80
Early research (Phase 1)Study completedNCT03335540
What this trial is testing

An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 20
Early research (Phase 1)Active Not RecruitingNCT06005740
What this trial is testing

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorHepatocellular Carcinoma
TORL Biotherapeutics, LLC 70
Large-scale testing (Phase 3)Study completedNCT00329940
What this trial is testing

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 200
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00074191
What this trial is testing

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 1
Not applicableStudy completedNCT01795690
What this trial is testing

Clinical Tumor Anemia Registry (TAR)

Who this might be right for
Anemia
iOMEDICO AG 1,018
Next Page